ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

22,335Medicare Part D Prescriptions Filled, Including Refills

Rank: 46 out of 1677

$1.13M Total Retail Price of All Prescriptions

Rank: 52 out of 1677

769 Patients Receiving at Least One Drug in Part D
79%Patients 65 Years and Older
51% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Georgia
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 769 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

20% of this provider’s 769 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

2% of this provider’s 19,301 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$50 was the average price of a prescription from this provider, compared to $53 among peers.

Prescriptions per Patient

29 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Georgia
SIMVASTATIN 1,180 1,083 1 1
LEVOTHYROXINE SODIUM 825 785 2 5
HYDROCODONE-ACETAMINOPHEN 710 491 S3 3 4
OMEPRAZOLE 663 588 4 6
FUROSEMIDE 620 553 5 8
LISINOPRIL 552 437 6 3
AMLODIPINE BESYLATE 423 391 7 2
CARVEDILOL 399 384 8 20
POTASSIUM CHLORIDE 396 376 9 14
MELOXICAM 370 321 10 27
ATORVASTATIN CALCIUM 367 341 11 13
METOPROLOL TARTRATE 360 297 12 12
METOPROLOL SUCCINATE 334 298 13 23
METFORMIN HCL 325 259 14 7
HYDROCHLOROTHIAZIDE 322 286 15 9
CITALOPRAM HBR 304 280 16 22
GABAPENTIN 302 269 17 11
ZOLPIDEM TARTRATE 291 216 18 15
LOSARTAN POTASSIUM 290 277 19 25
DIOVAN 254 229 20 45
WARFARIN SODIUM 242 237 21 24
POLYETHYLENE GLYCOL 3350 236 231 22 76
ATENOLOL 236 204 22 21
NAMENDA 233 233 24 39
TRAMADOL HCL 227 201 25 16
TAMSULOSIN HCL 219 201 26 34
ENALAPRIL MALEATE 214 202 27 82
NEXIUM 211 116 28 19
CLOPIDOGREL 183 148 29 32
CRESTOR 177 150 30 28
PRAVASTATIN SODIUM 169 135 31 10
FLUTICASONE PROPIONATE 163 113 32 29
DONEPEZIL HCL 159 159 33 30
LOSARTAN-HYDROCHLOROTHIAZIDE 157 151 34 42
AZITHROMYCIN 155 129 35 38
MIRTAZAPINE 152 150 36 62
PANTOPRAZOLE SODIUM 143 130 37 46
DIGOXIN 140 140 38 71
AMLODIPINE BESYLATE-BENAZEPRIL 131 131 39 59
ACTOS 131 121 39 104
DIOVAN HCT 130 112 41 66
PLAVIX 128 111 42 47
RANITIDINE HCL 120 102 43 18
SERTRALINE HCL 115 100 44 26
CARBIDOPA-LEVODOPA 111 102 45 131
ESCITALOPRAM OXALATE 111 99 45 80
SINGULAIR 107 72 47 97
RISPERIDONE 106 103 48 60
ALENDRONATE SODIUM 104 101 49 43
FLUOXETINE HCL 103 84 50 49
CYCLOBENZAPRINE HCL 102 64 R 51 52
GLIMEPIRIDE 102 88 51 33
SYNTHROID 100 97 53 55
CYMBALTA 97 71 54 58
ADVAIR DISKUS 96 89 55 54
BENICAR 95 95 56 178
FAMOTIDINE 94 90 57 41
CIPROFLOXACIN HCL 93 83 58 57
LOVASTATIN 88 66 59 35
MECLIZINE HCL 87 87 60 110
TRAZODONE HCL 87 56 60 37
LANTUS 86 60 62 44
VERAPAMIL ER 86 79 62 86
PROAIR HFA 83 61 64 50
VENLAFAXINE HCL ER 81 68 65 92
ALLOPURINOL 81 74 65 31
NIASPAN 81 69 65 128
SPIRIVA 81 62 65 74
PROMETHAZINE HCL 80 60 R 69 64
LIPITOR 79 76 70 101
QUETIAPINE FUMARATE 79 57 70 77
BENICAR HCT 78 78 72 194
DILTIAZEM ER 76 76 73 143
PAROXETINE HCL 76 68 73 67
DILTIAZEM 24HR ER 75 72 75 144
EXELON 74 74 76 119
ROPINIROLE HCL 74 46 76 79
ZETIA 74 62 76 75
OXYCODONE-ACETAMINOPHEN 73 58 S2 79 122
PHENYTOIN SODIUM EXTENDED 71 50 80 112
TERAZOSIN HCL 70 63 81 138
NYSTATIN 70 56 81 185
CLONIDINE HCL 68 53 83 36
PIOGLITAZONE HCL 66 62 R 84 252
RAMIPRIL 66 61 84 118
LISINOPRIL-HYDROCHLOROTHIAZIDE 66 63 84 17
LORAZEPAM 64 64 87 239
PREMARIN 64 46 R 87 109
DILTIAZEM 24HR CD 63 58 89 156
DETROL LA 63 63 89 185
LEVOFLOXACIN 63 59 89 84
BENAZEPRIL HCL 61 61 92 53
ALBUTEROL SULFATE 61 61 92 135
TRICOR 61 35 92 100
BUPROPION HCL 61 61 92 247
NOVOLOG 60 47 96 117
PRAMIPEXOLE DIHYDROCHLORIDE 57 55 97 172
CARISOPRODOL 56 0 R 98 68
ISOSORBIDE MONONITRATE ER 56 48 98 73
LEVEMIR 55 42 100 157
NAPROXEN 55 32 100 87
PROPRANOLOL HCL 54 54 102 154
GLYBURIDE-METFORMIN HCL 54 54 R 102 121
LYRICA 53 49 104 81
FENTANYL 52 28 S2 105 103
DIVALPROEX SODIUM 52 41 105 111
PREDNISONE 51 51 107 40
MONTELUKAST SODIUM 51 35 107 174
CELEBREX 50 48 109 102
TRIAMTERENE-HCTZ 50 35 109 61
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on June 7, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.